PharmaCyte Biotech Inc (PMCB) — Long-term Investment Intensity
PharmaCyte Biotech Inc (PMCB) has a Long-term Investment Intensity of 40.2% as of January 2026. Long-term investments of $22.47 Million represent 40.2% of total assets of $55.87 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check PMCB total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
PharmaCyte Biotech Inc Long-term Investment Intensity (2014–2025)
This chart shows how PharmaCyte Biotech Inc's Long-term Investment Intensity has evolved across 11 annual periods from 2014 to 2025. As of January 2026, the intensity stands at 40.2%, reflecting long-term investments of $22.47 Million against total assets of $55.87 Million USD. Explore PMCB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for PharmaCyte Biotech Inc (2014–2025)
The table below presents the year-by-year Long-term Investment Intensity for PharmaCyte Biotech Inc from 2014 to 2025, covering 11 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see PharmaCyte Biotech Inc stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 40.7% | $22.47 Million | $55.17 Million | ▲ +38.6 pp |
| 2023 | 2.1% | $1.57 Million | $73.28 Million | ▲ +0.4 pp |
| 2022 | 1.7% | $1.57 Million | $90.62 Million | ▼ -19.5 pp |
| 2021 | 21.2% | $1.57 Million | $7.40 Million | ▼ -4.3 pp |
| 2020 | 25.5% | $1.57 Million | $6.17 Million | ▼ -1.7 pp |
| 2019 | 27.2% | $1.57 Million | $5.78 Million | ▲ +2.7 pp |
| 2018 | 24.5% | $1.57 Million | $6.41 Million | ▲ +6.4 pp |
| 2017 | 18.1% | $1.57 Million | $8.67 Million | ▼ -3.8 pp |
| 2016 | 22.0% | $1.57 Million | $7.16 Million | ▲ +2.2 pp |
| 2015 | 19.8% | $1.57 Million | $7.95 Million | ▲ +2.9 pp |
| 2014 | 16.9% | $1.57 Million | $9.32 Million | — |